GBT
CBPO

Grove Bank & Trust’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Grove Bank & Trust’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-116
Closed -$9K – 516
2017
Q4 		$9K Hold
116
– – ﹤0.01% 453
2017
Q3 		$11K Sell
116
-360
-76% -$34.6K 0.01% 461
2017
Q2 		$54K Buy
476
+360
+310% +$40.2K 0.03% 248
2017
Q1 		$12K Buy
+116
New +$12.4K 0.01% 335

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Grove Bank & Trust's CBPO Position: Q1 2018 in Review

Grove Bank & Trust sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2018, closing a stake of 116 shares — an estimated $9K sold.

Grove Bank & Trust first reported a position in CBPO in Q1 2017 and held it in 4 quarters. The position peaked at $54K in Q2 2017. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2018.

  • Grove Bank & Trust reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2018 after selling out during the quarter.
  • Grove Bank & Trust sold 116 China Biologic Products Holdings, Inc. shares in Q1 2018, an estimated $9K.
  • Grove Bank & Trust first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 4 quarters.
  • Grove Bank & Trust's China Biologic Products Holdings, Inc. position peaked at $54K in Q2 2017.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2018.

Based on Grove Bank & Trust's 13F filing for Q1 2018, filed 7 May 2018.